世界のインスリングラルギン市場:成長動向・競争分析2020-2026

【英語タイトル】Global Insulin Glargine Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP01149)・商品コード:QYR20AP01149
・発行会社(調査会社):QYResearch
・発行日:2020年3月23日(※2024年版があります。お問い合わせください)
・ページ数:115
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、インスリングラルギンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、インスリングラルギンのグローバル市場動向、メーカー別競争状況、種類別市場規模(単回投与バイアル、プレフィルドシリンジ)、用途別市場規模(2型糖尿病治療、1型糖尿病治療)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・インスリングラルギンの種類別市場2015-2026:単回投与バイアル、プレフィルドシリンジ
・インスリングラルギンの用途別市場2015-2026:2型糖尿病治療、1型糖尿病治療
・インスリングラルギンの北米市場分析
・インスリングラルギンのアジア市場分析
・インスリングラルギンの中南米市場分析
・インスリングラルギンの中東・アフリカ市場分析
・関連企業情報:Sanofi-Aventis、Ganlee、Biocon
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a “peakless” profile (according to the insulin glargine package insert).Insulin glargine is a long-acting, man-made version of human insulin. Insulin glargine works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is Used for energy. It also stops the liver from producing more sugar.

There are two type of Insulin glargine, which are Single Dose Vial and Pre-filled Syringe in the market. Considering its function, Insulin glargine is Used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also Used to treat people with type 2 diabetes (condition in which the body does not Used insulin normally and, therefore, cannot control the amount of sugar in the blood) who need insulin to control their diabetes.

We can see that there are just a few companies produce Insulin glargine, the production of them almost approach to 70% of whole market. They have seted plant in Japan, China, German, India, North Americato produce Insulin glargine, and China is the largest plant for Insulin glargine in the world and also the largest consumption country. As the amount of diabetes of increasing of China, the Chinese market will be bigger than North America.

The Industry is affected by the economic development level and policy, so it’s important to put an eye to economic indexes and leaders’ prefer. With the global economic recovery, more and more people pay attention to care about personal health, especially in underdevelopment regions that have a large population and fast economic growth, the need of Insulin glargine will increase.
In 2019, the global Insulin Glargine market size was US$ 6174.3 million and is forecast to US$ 8150 million in 2026, growing at a CAGR of 4.0% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Insulin Glargine.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Insulin Glargine market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Insulin Glargine market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Insulin Glargine market. Readers of the report can become informed about current and future trends of the global Insulin Glargine market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Insulin Glargine markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Insulin Glargine market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Insulin Glargine market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Insulin Glargine market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Insulin Glargine market is segmented into
Single Dose Vial
Pre-filled Syringe

Market Segment by Application, the Insulin Glargine market is segmented into
Treat type2 diabetes
Treat type1 diabetes

This report includes the following manufacturers; we can also add the other companies as you want.
Sanofi-Aventis
Ganlee
Biocon

The study objectives are:
To analyze and research the global Insulin Glargine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Insulin Glargine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Insulin Glargine are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Insulin Glargine Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Insulin Glargine Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Single Dose Vial
1.3.3 Pre-filled Syringe
1.4 Market Segment by Application
1.4.1 Global Insulin Glargine Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Treat type2 diabetes
1.4.3 Treat type1 diabetes
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Insulin Glargine Revenue (2015-2026)
2.1.1 Global Insulin Glargine Revenue (2015-2026)
2.1.2 Global Insulin Glargine Sales (2015-2026)
2.2 Insulin Glargine Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Insulin Glargine Sales by Regions (2015-2020)
2.2.2 Global Insulin Glargine Revenue by Regions (2015-2020)
2.3 Global Top Insulin Glargine Regions (Countries) Ranking by Market Size
2.4 Insulin Glargine Industry Trends
2.4.1 Insulin Glargine Market Top Trends
2.4.2 Market Drivers
2.4.3 Insulin Glargine Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Insulin Glargine Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Insulin Glargine Manufacturers by Sales (2015-2020)
3.1.1 Global Insulin Glargine Sales by Manufacturers (2015-2020)
3.1.2 Global Insulin Glargine Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Insulin Glargine Sales in 2019
3.2 Global Top Manufacturers Insulin Glargine by Revenue
3.2.1 Global Insulin Glargine Revenue by Manufacturers (2015-2020)
3.2.2 Global Insulin Glargine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Insulin Glargine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Glargine as of 2019)
3.4 Global Insulin Glargine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Insulin Glargine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Insulin Glargine Market
3.7 Key Manufacturers Insulin Glargine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Insulin Glargine Historic Market Review by Type (2015-2020)
4.1.2 Global Insulin Glargine Sales Market Share by Type (2015-2020)
4.1.3 Global Insulin Glargine Revenue Market Share by Type (2015-2020)
4.1.4 Insulin Glargine Price by Type (2015-2020)
4.1 Global Insulin Glargine Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Insulin Glargine Sales Forecast by Type (2021-2026)
4.2.3 Global Insulin Glargine Revenue Forecast by Type (2021-2026)
4.2.4 Insulin Glargine Price Forecast by Type (2021-2026)

5 Global Insulin Glargine Market Size by Application
5.1 Global Insulin Glargine Historic Market Review by Application (2015-2020)
5.1.2 Global Insulin Glargine Sales Market Share by Application (2015-2020)
5.1.3 Global Insulin Glargine Revenue Market Share by Application (2015-2020)
5.1.4 Insulin Glargine Price by Application (2015-2020)
5.2 Global Insulin Glargine Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Insulin Glargine Sales Forecast by Application (2021-2026)
5.2.3 Global Insulin Glargine Revenue Forecast by Application (2021-2026)
5.2.4 Insulin Glargine Price Forecast by Application (2021-2026)

6 North America
6.1 North America Insulin Glargine Breakdown Data by Company
6.2 North America Insulin Glargine Breakdown Data by Type
6.3 North America Insulin Glargine Breakdown Data by Application
6.4 North America Insulin Glargine Breakdown Data by Countries
6.4.1 North America Insulin Glargine Sales by Countries
6.4.2 North America Insulin Glargine Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Insulin Glargine Breakdown Data by Company
7.2 Europe Insulin Glargine Breakdown Data by Type
7.3 Europe Insulin Glargine Breakdown Data by Application
7.4 Europe Insulin Glargine Breakdown Data by Countries
7.4.1 Europe Insulin Glargine Sales by Countries
7.4.2 Europe Insulin Glargine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Insulin Glargine Breakdown Data by Company
8.2 Asia Pacific Insulin Glargine Breakdown Data by Type
8.3 Asia Pacific Insulin Glargine Breakdown Data by Application
8.4 Asia Pacific Insulin Glargine Breakdown Data by Regions
8.4.1 Asia Pacific Insulin Glargine Sales by Regions
8.4.2 Asia Pacific Insulin Glargine Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Insulin Glargine Breakdown Data by Company
9.2 Latin America Insulin Glargine Breakdown Data by Type
9.3 Latin America Insulin Glargine Breakdown Data by Application
9.4 Latin America Insulin Glargine Breakdown Data by Countries
9.4.1 Latin America Insulin Glargine Sales by Countries
9.4.2 Latin America Insulin Glargine Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Insulin Glargine Breakdown Data by Type
10.2 Middle East and Africa Insulin Glargine Breakdown Data by Application
10.3 Middle East and Africa Insulin Glargine Breakdown Data by Countries
10.3.1 Middle East and Africa Insulin Glargine Sales by Countries
10.3.2 Middle East and Africa Insulin Glargine Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Corporation Information
11.1.2 Sanofi-Aventis Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Sanofi-Aventis Insulin Glargine Products and Services
11.1.5 Sanofi-Aventis SWOT Analysis
11.1.6 Sanofi-Aventis Recent Developments
11.2 Ganlee
11.2.1 Ganlee Corporation Information
11.2.2 Ganlee Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Ganlee Insulin Glargine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Ganlee Insulin Glargine Products and Services
11.2.5 Ganlee SWOT Analysis
11.2.6 Ganlee Recent Developments
11.3 Biocon
11.3.1 Biocon Corporation Information
11.3.2 Biocon Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Biocon Insulin Glargine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Biocon Insulin Glargine Products and Services
11.3.5 Biocon SWOT Analysis
11.3.6 Biocon Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Insulin Glargine Sales Channels
12.2.2 Insulin Glargine Distributors
12.3 Insulin Glargine Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Insulin Glargine Sales Forecast (2021-2026)
13.1.1 Global Insulin Glargine Sales Forecast by Regions (2021-2026)
13.1.2 Global Insulin Glargine Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Insulin Glargine Sales Forecast (2021-2026)
13.2.2 North America Insulin Glargine Revenue Forecast (2021-2026)
13.2.3 North America Insulin Glargine Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Insulin Glargine Sales Forecast (2021-2026)
13.3.2 Europe Insulin Glargine Revenue Forecast (2021-2026)
13.3.3 Europe Insulin Glargine Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Insulin Glargine Sales Forecast (2021-2026)
13.4.2 Asia Pacific Insulin Glargine Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Insulin Glargine Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Insulin Glargine Sales Forecast (2021-2026)
13.5.2 Latin America Insulin Glargine Revenue Forecast (2021-2026)
13.5.3 Latin America Insulin Glargine Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Insulin Glargine Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Insulin Glargine Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Insulin Glargine Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Insulin Glargine Key Market Segments
Table 2. Ranking of Global Top Insulin Glargine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Glargine Market Size Growth Rate by Type 2021-2026 (M mL) & (Million US$)
Table 4. Major Manufacturers of Single Dose Vial
Table 5. Major Manufacturers of Pre-filled Syringe
Table 6. Global Insulin Glargine Market Share by Application 2019-2025 (M mL)
Table 7. Global Insulin Glargine Market Size by Regions 2015-2020 (M mL) & (Million US$)
Table 8. Global Insulin Glargine Sales by Regions 2015-2020 (M mL)
Table 9. Global Insulin Glargine Sales Market Share by Regions 2015-2020
Table 10. Global Insulin Glargine Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Insulin Glargine Revenue Market Share by Regions 2015-2020
Table 12. Top Insulin Glargine Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Insulin Glargine Key Drivers: Impact Analysis (2021-2026)
Table 15. Insulin Glargine Key Challenges
Table 16. Main Points Interviewed from Key Insulin Glargine Players: Views for Future
Table 17. Global Insulin Glargine Sales by Manufacturers (2015-2020) (M mL)
Table 18. Global Insulin Glargine Sales Share by Manufacturers (2015-2020)
Table 19. Insulin Glargine Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Insulin Glargine Revenue Share by Manufacturers (2015-2020)
Table 21. Global Insulin Glargine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Glargine as of 2019)
Table 23. Key Manufacturers Insulin Glargine Average Selling Price (ASP) (2015-2020) (USD/mL)
Table 24. Key Manufacturers Insulin Glargine Plants/Factories Distribution
Table 25. Key Manufacturers Insulin Glargine Area Served
Table 26. Date of Key Manufacturers Enter into Insulin Glargine Market
Table 27. Key Manufacturers Insulin Glargine Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Single Dose Vial Sales and Revenue (2015-2020) (M mL) & (Million US$)
Table 30. Global Pre-filled Syringe Sales and Revenue (2015-2020) (M mL) & (Million US$)
Table 31. Global Insulin Glargine Sales (M mL) by Type (2015-2020)
Table 32. Global Insulin Glargine Sales Share by Type (2015-2020)
Table 33. Global Insulin Glargine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Insulin Glargine Price (M mL) by Type (2015-2020)
Table 35. Global Insulin Glargine Sales (M mL) by Type (2021-2026)
Table 36. Global Insulin Glargine Sales Share by Type (2021-2026)
Table 37. Global Insulin Glargine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Insulin Glargine Revenue Share by Type (2021-2026)
Table 39. Global Insulin Glargine Price (M mL) by Type (2021-2026)
Table 40. Global Insulin Glargine Sales (M mL) by Application (2015-2020)
Table 41. Global Insulin Glargine Sales Share by Application (2015-2020)
Table 42. Global Insulin Glargine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Insulin Glargine Price by Application 2015-2020 (USD/mL)
Table 44. Global Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 45. Global Insulin Glargine Sales Share by Application (2015-2020)
Table 46. Global Insulin Glargine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Insulin Glargine Revenue Share by Application (2021-2026)
Table 48. Global Insulin Glargine Price (M mL) by Application (2021-2026)
Table 49. North America Insulin Glargine Sales by Company (2015-2020) (M mL)
Table 50. North America Insulin Glargine Sales Market Share by Company (2015-2020)
Table 51. North America Insulin Glargine Sales by Type (2015-2020) (M mL)
Table 52. North America Insulin Glargine Sales Market Share by Type (2015-2020)
Table 53. North America Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 54. North America Insulin Glargine Sales Market Share by Application (2015-2020)
Table 55. North America Insulin Glargine Sales by Countries (2015-2020) (M mL)
Table 56. North America Insulin Glargine Sales Market Share by Countries (2015-2020)
Table 57. North America Insulin Glargine Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Insulin Glargine Revenue Market Share by Countries (2015-2020)
Table 59. Europe Insulin Glargine Sales by Company (2015-2020) (M mL)
Table 60. Europe Insulin Glargine Sales Market Share by Company (2015-2020)
Table 61. Europe Insulin Glargine Sales by Type (2015-2020) (M mL)
Table 62. Europe Insulin Glargine Sales Market Share by Type (2015-2020)
Table 63. Europe Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 64. Europe Insulin Glargine Sales Market Share by Application (2015-2020)
Table 65. Europe Insulin Glargine Sales by Countries (2015-2020) (M mL)
Table 66. Europe Insulin Glargine Sales Market Share by Countries (2015-2020)
Table 67. Europe Insulin Glargine Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Insulin Glargine Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Insulin Glargine Sales by Regions (2015-2020) (M mL)
Table 70. Asia Pacific Insulin Glargine Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Insulin Glargine Sales by Type (2015-2020) (M mL)
Table 72. Asia Pacific Insulin Glargine Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 74. Asia Pacific Insulin Glargine Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Insulin Glargine Sales by Countries (2015-2020) (M mL)
Table 76. Asia Pacific Insulin Glargine Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Insulin Glargine Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Insulin Glargine Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Insulin Glargine Sales by Company (2015-2020) (M mL)
Table 80. Latin America Insulin Glargine Sales Market Share by Company (2015-2020)
Table 81. Latin America Insulin Glargine Sales by Type (2015-2020) (M mL)
Table 82. Latin America Insulin Glargine Sales Market Share by Type (2015-2020)
Table 83. Latin America Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 84. Latin America Insulin Glargine Sales Market Share by Application (2015-2020)
Table 85. Latin America Insulin Glargine Sales by Countries (2015-2020) (M mL)
Table 86. Latin America Insulin Glargine Sales Market Share by Countries (2015-2020)
Table 87. Latin America Insulin Glargine Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Insulin Glargine Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Insulin Glargine Sales by Type (2015-2020) (M mL)
Table 90. Middle East and Africa Insulin Glargine Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Insulin Glargine Sales by Application (2015-2020) (M mL)
Table 92. Middle East and Africa Insulin Glargine Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Insulin Glargine Sales by Countries (2015-2020) (M mL)
Table 94. Middle East and Africa Insulin Glargine Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Insulin Glargine Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Insulin Glargine Revenue Market Share by Countries (2015-2020)
Table 97. Sanofi-Aventis Company Details
Table 98. Sanofi-Aventis Description and Business Overview
Table 99. Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue (Million US$), Price (USD/mL) and Gross Margin (2015-2020)
Table 100. Sanofi-Aventis Insulin Glargine Sales Growth Rate (2015-2020)
Table 101. Sanofi-Aventis Insulin Glargine Sales Market Share in Global Market
Table 102. Sanofi-Aventis Recent Development
Table 103. Ganlee Company Details
Table 104. Ganlee Description and Business Overview
Table 105. Ganlee Insulin Glargine Sales (M mL), Revenue (Million US$), Price (USD/mL) and Gross Margin (2015-2020)
Table 106. Ganlee Insulin Glargine Sales Growth Rate (2015-2020)
Table 107. Ganlee Insulin Glargine Sales Market Share in Global Market
Table 108. Ganlee Recent Development
Table 109. Biocon Company Details
Table 110. Biocon Description and Business Overview
Table 111. Biocon Insulin Glargine Sales (M mL), Revenue (Million US$), Price (USD/mL) and Gross Margin (2015-2020)
Table 112. Biocon Insulin Glargine Sales Growth Rate (2015-2020)
Table 113. Biocon Insulin Glargine Sales Market Share in Global Market
Table 114. Biocon Recent Development
Table 115. Insulin Glargine Distributors List
Table 116. Insulin Glargine Customers List
Table 117. Global Insulin Glargine Sales Forecast 2021-2026 (M mL) & (Million US$)
Table 118. Global Insulin Glargine Sales Forecast by Type 2021-2026 (M mL)
Table 119. Global Insulin Glargine Sales Forecast by Application 2021-2026 (M mL)
Table 120. Global Insulin Glargine Sales Forecast by Regions 2021-2026 (M mL)
Table 121. Global Insulin Glargine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 122. North America Insulin Glargine Sales Forecast by Countries 2021-2026 (M mL)
Table 123. North America Insulin Glargine Revenue Forecast by Countries 2021-2026
Table 124. Europe Insulin Glargine Sales Forecast by Countries 2021-2026 (M mL)
Table 125. Europe Insulin Glargine Revenue Market Share Forecast by Countries 2021-2026
Table 126. Asia Pacific Insulin Glargine Sales Forecast by Regions 2021-2026 (M mL)
Table 127. Asia Pacific Insulin Glargine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 128. Latin America Insulin Glargine Sales Forecast by Countries 2021-2026 (M mL)
Table 129. Latin America Insulin Glargine Revenue Forecast by Countries 2021-2026 (Million US$)
Table 130. Middle East and Africa Insulin Glargine Sales Forecast by Regions 2021-2026 (M mL)
Table 131. Middle East and Africa Insulin Glargine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Glargine Product Picture
Figure 2. Global Insulin Glargine Sales Market Shar by Type 2015-2026
Figure 3. Single Dose Vial Figures
Figure 4. Pre-filled Syringe Figures
Figure 5. Global Insulin Glargine Sales Market Share by Application in 2019 & 2026
Figure 6. Treat type2 diabetes Use Case
Figure 7. Treat type1 diabetes Use Case
Figure 8. Insulin Glargine Report Years Considered
Figure 9. Global Insulin Glargine Market Size 2015-2026 (Million US$)
Figure 10. Global Insulin Glargine Sales 2015-2020 (M mL)
Figure 11. Global Insulin Glargine Market Size Market Share by Regions 2015-2020
Figure 12. Global Insulin Glargine Sales Market Share by Regions in 2019
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Insulin Glargine Sales Share by Manufacturers in 2019
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Glargine Sales in 2019
Figure 16. Insulin Glargine Value Share by Manufacturers in 2019
Figure 17. Insulin Glargine Revenue Share by Manufacturers In 2019
Figure 18. Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Insulin Glargine Revenue Share by Type (2015-2020)
Figure 20. Global Insulin Glargine Revenue Growth Rate by Type in 2015 & 2019
Figure 21. Global Insulin Glargine Market Share by Price Range (2015-2020)
Figure 22. Global Insulin Glargine Revenue Share by Application (2015-2020)
Figure 23. Global Insulin Glargine Revenue Growth Rate by Application in 2015 & 2019
Figure 24. North America Insulin Glargine Revenue Growth Rate 2015-2020 (Million US$)
Figure 25. U.S. Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 26. Canada Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 27. Europe Insulin Glargine Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. Germany Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 29. France Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 30. U.K. Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 31. Italy Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 32. Russia Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 33. Asia Pacific Insulin Glargine Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. China Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 35. Japan Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 36. South Korea Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 37. India Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 38. Australia Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 39. Taiwan Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 40. Indonesia Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 41. Thailand Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 42. Malaysia Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 43. Philippines Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 44. Vietnam Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 45. Latin America Insulin Glargine Revenue Growth Rate 2015-2020 (Million US$)
Figure 46. Mexico Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 47. Brazil Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 48. Argentina Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 49. Middle East and Africa Insulin Glargine Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Turkey Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 51. Saudi Arabia Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 52. U.A.E Insulin Glargine Sales Growth Rate (2015-2020) (M mL)
Figure 53. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Ganlee Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Insulin Glargine Value Chain
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. North America Insulin Glargine Sales Growth Rate Forecast (2021-2026) (M mL)
Figure 60. North America Insulin Glargine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 61. Europe Insulin Glargine Sales Growth Rate Forecast (2021-2026) (M mL)
Figure 62. Europe Insulin Glargine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 63. Asia Pacific Insulin Glargine Sales Growth Rate Forecast (2021-2026) (M mL)
Figure 64. Asia Pacific Insulin Glargine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 65. Latin America Insulin Glargine Sales Growth Rate Forecast (2021-2026) (M mL)
Figure 66. Latin America Insulin Glargine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 67. Middle East and Africa Insulin Glargine Sales Growth Rate Forecast (2021-2026) (M mL)
Figure 68. Middle East and Africa Insulin Glargine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


【掲載企業】

Sanofi-Aventis、Ganlee、Biocon

★調査レポート[世界のインスリングラルギン市場:成長動向・競争分析2020-2026] (コード:QYR20AP01149)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のインスリングラルギン市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆